Reglan

The FDA on February 26, 2009 issued a News Release announcing that the highest warning, a black box was required because of a link between Metoclopramide and tardive dyskinesia(involuntary movements of parts of the body, which may last indefinitely).

Tardive dyskinesia is a terrible neurologic disease characterized by repetitive, involuntary, purposeless movements such as grimacing, lip smacking, eye blinking or rapid leg and arm movements. It can be irreversible though symptoms may lessen or resolve after discontinuing drug.

The makers of this drug had long played a dangerous game of promoting Reglan for use as a long term therapy for gastrointestinal complaints including GERD (Gastroesophageal Reflux Disease) despite awareness that the drug had not been approved for use beyond 12 weeks.

Companies selling Reglan knew:

– That Reglan caused tardive dyskinesia

– That the longer Reglan was used, the greater the risk.

– Almost half the patients taking Reglan were using it longer than 12 weeks.

Until forced by the FDA the companies did not warn doctors that the drug was unreasonably dangerous for use more than 12 weeks.

Now under the compulsion of the FDA companies marketing the product are required to warn: “Treatment with metoclopramide for longer than 12 weeks should be avoided in all but rare cases where therapeutic benefit is thought to outweigh the risk of developing TD.”

If you or a loved one used Reglan, and suffered from any of the injuries mentioned or other side effects associated with this product, you may have a claim.

Have a Question?

Please Contact Us using our Contact page
or by calling Toll-Free: (800) 664-1734

Recent Posts about Drugs and Pharmaceuticals

United States v. Barry Cadden – Jury Returns Mixed Verdict in Trial of NECC Co-Founder

United States v. Barry Cadden – Jury Returns Mixed Verdict in Trial of NECC Co-Founder

The jury returned its verdict this morning, finding Barry Cadden, co-founder of the now-defunct [...]
URGENT RECALL: BRAVELLE® FOLLICLE-STIMULATING HORMONE RECALLED FOR LACK OF EFFICACY

URGENT RECALL: BRAVELLE® FOLLICLE-STIMULATING HORMONE RECALLED FOR LACK OF EFFICACY

URGENT RECALL: BRAVELLE® FOLLICLE-STIMULATING HORMONE RECALLED FOR LACK OF EFFICACY In October[...]
Federal Judge Confirms $200 Million Settlement for Victims Injured by Tainted NECC Steroids

Federal Judge Confirms $200 Million Settlement for Victims Injured by Tainted NECC Steroids

Springfield, Mass. - Yesterday, Federal Bankruptcy Judge Henry Boroff ruled in open court confirming[...]
No thumbnail available

Male Testosterone Supplements Linked to Increased Risk of Heart Attack & Stroke

Abbott Labs is under fire after several users of its Androgel® testosterone replacement drug cla[...]
Unexpected Breast Growth from Risperdal Traumatizes Young Men

Unexpected Breast Growth from Risperdal Traumatizes Young Men

Just before the first trial involving Risperdal® (Risperidone) began in Pennsylvania state court[...]
Andrews Thornton Higgins Razmara Investigates ADHD Medications Linked to Priapism in Men

Andrews Thornton Higgins Razmara Investigates ADHD Medications Linked to Priapism in Men

The FDA warns that a class of medications used to treat attention deficit hyperactivity disorder (AD[...]
No thumbnail available

Andrews Thornton Higgins Razmara Hand-Delivers NECC Bankruptcy Claims

In order to guarantee proper and timely filing of over 150 claims in the New England Compounding[...]
No thumbnail available

New Law Helps Ensure Compounding Pharmacy Safety

The FDA has implemented a new law concerning compounding pharmacies that is designed to protect [...]